Patents by Inventor Rongxin SHI

Rongxin SHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PARATHYROID HORMONE VARIANTS
    Publication number: 20230340057
    Abstract: The invention relates to parathyroid hormone (PTH) variants and pharmaceutical compositions comprising same. The invention further relates to PTH compositions with improved serum half-life and peak-trough ratios, and methods of controlling serum calcium levels with the PTH variants and compositions of the invention. The invention further relates to methods of treating hypoparathyroidism and/or hypocalcemia due to hypoparathyroidism with the PTH variants and compositions of the invention.
    Type: Application
    Filed: March 2, 2023
    Publication date: October 26, 2023
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Clark PAN, Angela NORTON, Kevin HOLMES, David LLOYD, Bryan GOODWIN, Rongxin SHI, Sujit JAIN, Chuan SHEN
  • Parathyroid hormone variants
    Patent number: 11634468
    Abstract: The invention relates to parathyroid hormone (PTH) variants and pharmaceutical compositions comprising same. The invention further relates to PTH compositions with improved serum half-life and peak-trough ratios, and methods of controlling serum calcium levels with the PTH variants and compositions of the invention. The invention further relates to methods of treating hypoparathyroidism and/or hypocalcemia due to hypoparathyroidism with the PTH variants and compositions of the invention.
    Type: Grant
    Filed: January 29, 2020
    Date of Patent: April 25, 2023
    Assignee: SHIRE-NPS PHARMACEUTICALS, INC.
    Inventors: Clark Pan, Angela Norton, Kevin Holmes, David Bruce Lloyd, Bryan James Goodwin, Rongxin Shi, Sujit Jain, Chuan Shen
  • PARATHYROID HORMONE VARIANTS
    Publication number: 20200247865
    Abstract: The invention relates to parathyroid hormone (PTH) variants and pharmaceutical compositions comprising same. The invention further relates to PTH compositions with improved serum half-life and peak-trough ratios, and methods of controlling serum calcium levels with the PTH variants and compositions of the invention. The invention further relates to methods of treating hypoparathyroidism and/or hypocalcemia due to hypoparathyroidism with the PTH variants and compositions of the invention.
    Type: Application
    Filed: January 29, 2020
    Publication date: August 6, 2020
    Applicant: Shire-NPS Pharmaceuticals, Inc.
    Inventors: Clark PAN, Angela NORTON, Kevin HOLMES, David Bruce LLOYD, Bryan James GOODWIN, Rongxin SHI, Sujit JAIN, Chuan SHEN